5.96
price up icon0.17%   0.010
pre-market  プレマーケット:  5.99   0.03   +0.50%
loading
前日終値:
$5.95
開ける:
$6
24時間の取引高:
1.07M
Relative Volume:
0.57
時価総額:
$523.54M
収益:
$30.91M
当期純損益:
$-209.47M
株価収益率:
-1.7909
EPS:
-3.3279
ネットキャッシュフロー:
$-147.13M
1週間 パフォーマンス:
+9.16%
1か月 パフォーマンス:
+5.86%
6か月 パフォーマンス:
-26.96%
1年 パフォーマンス:
-14.98%
1日の値動き範囲:
Value
$5.825
$6.08
1週間の範囲:
Value
$5.185
$6.08
52週間の値動き範囲:
Value
$4.01
$11.24

Verastem Inc Stock (VSTM) Company Profile

Name
名前
Verastem Inc
Name
セクター
Healthcare (1106)
Name
電話
(781) 292-4200
Name
住所
117 KENDRICK STREET, NEEDHAM, MA
Name
職員
102
Name
次回の収益日
2026-05-07
Name
最新のSEC提出書
Name
VSTM's Discussions on Twitter

Compare VSTM vs VRTX, REGN, ARGX, ALNY, ONC

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
VSTM icon
VSTM
Verastem Inc
5.96 523.54M 30.91M -209.47M -147.13M -3.3279
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
424.36 107.87B 12.32B 4.34B 3.19B 16.86
REGN icon
REGN
Regeneron Pharmaceuticals Inc
702.27 73.63B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
794.70 49.42B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
301.11 40.20B 3.71B 313.75M 465.38M 2.2571
ONC icon
ONC
Beone Medicines Ltd Adr
297.49 33.06B 5.36B 287.73M 924.18M 2.5229

Verastem Inc Stock (VSTM) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-03-12 再開されました BTIG Research Buy
2026-02-04 開始されました H.C. Wainwright Buy
2025-10-16 再開されました Cantor Fitzgerald Overweight
2025-04-10 開始されました Jefferies Buy
2025-03-24 繰り返されました H.C. Wainwright Buy
2024-12-31 繰り返されました BTIG Research Buy
2024-09-30 開始されました Guggenheim Buy
2023-11-21 再開されました BTIG Research Buy
2023-09-27 開始されました B. Riley Securities Buy
2023-06-15 アップグレード Mizuho Neutral → Buy
2022-09-07 再開されました Alliance Global Partners Buy
2022-04-29 再開されました Cantor Fitzgerald Overweight
2022-04-14 開始されました RBC Capital Mkts Outperform
2022-03-09 開始されました Truist Buy
2021-07-01 開始されました Alliance Global Partners Buy
2021-05-24 アップグレード BTIG Research Neutral → Buy
2019-06-20 ダウングレード BTIG Research Buy → Neutral
2019-05-10 ダウングレード Raymond James Outperform → Mkt Perform
2018-07-13 開始されました BTIG Research Buy
2018-05-02 開始されました Seaport Global Securities Buy
2018-03-08 開始されました B. Riley FBR, Inc. Buy
2017-09-07 繰り返されました H.C. Wainwright Buy
2017-04-13 開始されました Oppenheimer Outperform
2017-03-24 繰り返されました H.C. Wainwright Buy
2015-09-29 ダウングレード Cantor Fitzgerald Buy → Hold
2015-09-29 ダウングレード JMP Securities Mkt Outperform → Mkt Perform
2015-09-29 ダウングレード Jefferies Buy → Hold
2015-09-29 ダウングレード Raymond James Strong Buy → Outperform
2015-09-28 ダウングレード Mizuho Buy → Neutral
2015-09-28 ダウングレード ROTH Capital Buy → Neutral
2015-09-09 開始されました Raymond James Strong Buy
2015-05-12 繰り返されました UBS Buy
2015-04-08 開始されました H.C. Wainwright Buy
2015-01-23 繰り返されました ROTH Capital Buy
2014-07-08 再開されました Oppenheimer Perform
2014-02-11 開始されました Mizuho Buy
すべてを表示

Verastem Inc (VSTM) 最新ニュース

pulisher
May 04, 2026

MSN Money - MSN

May 04, 2026
pulisher
May 01, 2026

Earnings Preview: Verastem to Report Financial Results on May 07 - Moomoo

May 01, 2026
pulisher
Apr 30, 2026

Verastem Oncology Launches HCP and Patient Reimagine Campaign to Increase Awareness of AVMAPKI® FAKZYNJA® CO-PACK for KRAS-Mutated Recurrent Low-Grade Serous Ovarian Cancer - BioSpace

Apr 30, 2026
pulisher
Apr 30, 2026

Verastem (VSTM) Launches Campaign for Recurrent Low-Grade Serous Ovarian Cancer - GuruFocus

Apr 30, 2026
pulisher
Apr 30, 2026

KRAS-mutated LGSOC campaign debuts as Verastem, Inc. targets patient support - Traders Union

Apr 30, 2026
pulisher
Apr 30, 2026

Verastem (VSTM) Projected to Post Earnings on Thursday - MarketBeat

Apr 30, 2026
pulisher
Apr 29, 2026

Mizuho Securities Adjusts Verastem Price Target to $16 From $18, Maintains Outperform Rating - marketscreener.com

Apr 29, 2026
pulisher
Apr 28, 2026

CapEx per share of Verastem, Inc. – MUN:2VSA - TradingView

Apr 28, 2026
pulisher
Apr 27, 2026

Verastem to Present at the 8th Annual JMP Securities Healthcare Conference - AOL.com

Apr 27, 2026
pulisher
Apr 27, 2026

Liquidity Mapping Around (VSTM) Price Events - Stock Traders Daily

Apr 27, 2026
pulisher
Apr 26, 2026

Verastem Oncology announces management changes - MSN

Apr 26, 2026
pulisher
Apr 24, 2026

VSTM Price Today: Verastem, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange

Apr 24, 2026
pulisher
Apr 24, 2026

Verastem, Inc. (NASDAQ:VSTM) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Apr 24, 2026
pulisher
Apr 23, 2026

VSTM Reiterated by BTIG -- Price Target Maintained at $19.00 - GuruFocus

Apr 23, 2026
pulisher
Apr 23, 2026

Torray Investment Partners LLC Purchases Shares of 216,387 Verastem, Inc. $VSTM - MarketBeat

Apr 23, 2026
pulisher
Apr 23, 2026

Verastem, Inc. sets first quarter earnings call for May 7 at 4:30pm ET - Traders Union

Apr 23, 2026
pulisher
Apr 23, 2026

Verastem Oncology to Report First Quarter 2026 Financial Results on May 7, 2026 - ChartMill

Apr 23, 2026
pulisher
Apr 22, 2026

VSTM Technical Analysis | Trend, Signals & Chart Patterns | VERASTEM INC (NASDAQ:VSTM) - ChartMill

Apr 22, 2026
pulisher
Apr 21, 2026

Verastem Inc stock (US92335V1008): Is its oncology pipeline strong enough to unlock biotech upside? - AD HOC NEWS

Apr 21, 2026
pulisher
Apr 21, 2026

BTIG Maintains Verastem(VSTM.US) With Buy Rating, Maintains Target Price $19 - Moomoo

Apr 21, 2026
pulisher
Apr 20, 2026

Verastem's (VSTM) Buy Rating Reaffirmed at BTIG Research - MarketBeat

Apr 20, 2026
pulisher
Apr 20, 2026

Verastem (NASDAQ:VSTM) Trading Down 4.1%Here's Why - MarketBeat

Apr 20, 2026
pulisher
Apr 20, 2026

Verastem (VSTM) Stock Growth Drivers (Momentum Fading) 2026-04-20Retail Trader Ideas - Cổng thông tin điện tử tỉnh Lào Cai

Apr 20, 2026
pulisher
Apr 20, 2026

Vectoring In On Verastem (NASDAQ:VSTM) - Seeking Alpha

Apr 20, 2026
pulisher
Apr 19, 2026

Verastem Inc stock (US92335V1008): Is its cancer therapy pipeline strong enough to unlock new upside - AD HOC NEWS

Apr 19, 2026
pulisher
Apr 18, 2026

Verastem (VSTM) Stock: Cheap or Expensive (+3.79%) 2026-04-18Social Trade Signals - Cổng thông tin điện tử tỉnh Lào Cai

Apr 18, 2026
pulisher
Apr 18, 2026

Verastem (VSTM) Stock: Is It a Strong Buy? (Extends Gains) 2026-04-18Trend Analysis - Cổng thông tin điện tử tỉnh Lào Cai

Apr 18, 2026
pulisher
Apr 17, 2026

Verastem, Inc. (VSTM) Stock Analysis: 158% Potential Upside Sparks Investor Interest - DirectorsTalk Interviews

Apr 17, 2026
pulisher
Apr 17, 2026

VSTM Stock Chart | VERASTEM INC (NASDAQ:VSTM) - ChartMill

Apr 17, 2026
pulisher
Apr 16, 2026

Why (VSTM) Price Action Is Critical for Tactical Trading - Stock Traders Daily

Apr 16, 2026
pulisher
Apr 16, 2026

Mizuho Securities Maintains Verastem(VSTM.US) With Buy Rating, Maintains Target Price $16 - Moomoo

Apr 16, 2026
pulisher
Apr 15, 2026

Q4 2025 Verastem Inc Earnings Call Transcript - GuruFocus

Apr 15, 2026
pulisher
Apr 14, 2026

Verastem Stock Rises Nearly 8% on Strong Q4 & 2025 Preliminary Results - Eastern Progress

Apr 14, 2026
pulisher
Apr 14, 2026

PI3K Inhibitor Drug Class Market (2026-2033) | PI3Kα, PI3Kβ, - openPR.com

Apr 14, 2026
pulisher
Apr 13, 2026

Chipmakers Recap: How is Verastem Inc managing supply chain issues2026 Support & Resistance & Long Hold Capital Preservation Tips - baoquankhu1.vn

Apr 13, 2026
pulisher
Apr 13, 2026

Verastem (NASDAQ:VSTM) Trading Up 7.6%What's Next? - MarketBeat

Apr 13, 2026
pulisher
Apr 13, 2026

Aug Wrap: What analysts say about Verastem Inc stock2026 Bull vs Bear & Weekly High Return Forecasts - baoquankhu1.vn

Apr 13, 2026
pulisher
Apr 13, 2026

H.C. Wainwright reiterates Verastem stock rating on durable trial data By Investing.com - Investing.com Canada

Apr 13, 2026
pulisher
Apr 13, 2026

Is momentum building in Verastem (VSTM) Stock | Price at $5.63, Up 6.03%Trade Ideas - UBND thành phố Hải Phòng

Apr 13, 2026
pulisher
Apr 11, 2026

Sentiment Recap: What analysts say about Verastem Inc stockTrade Entry Report & AI Optimized Trade Strategies - baoquankhu1.vn

Apr 11, 2026
pulisher
Apr 10, 2026

Verastem Oncology’s combo shows two-year durability in ovarian cancer - MSN

Apr 10, 2026
pulisher
Apr 10, 2026

Fed Meeting: What is the Moat Score of Verastem IncQuarterly Earnings Report & Consistent Income Trade Recommendations - baoquankhu1.vn

Apr 10, 2026
pulisher
Apr 10, 2026

Today's Analyst Rating Data for VSTM: Maintained Buy Rating | VS - GuruFocus

Apr 10, 2026
pulisher
Apr 10, 2026

Today's Analyst Rating for VSTM: Maintains Buy Rating at $18.00 | VSTM Stock News - GuruFocus

Apr 10, 2026
pulisher
Apr 10, 2026

Today's Analyst Rating for VSTM: Maintains Buy Rating at $18.00 - GuruFocus

Apr 10, 2026
pulisher
Apr 10, 2026

Verastem stock maintains Buy rating at BTIG on durable trial data - Investing.com Canada

Apr 10, 2026
pulisher
Apr 10, 2026

Verastem (NASDAQ:VSTM) Earns "Buy" Rating from BTIG Research - MarketBeat

Apr 10, 2026
pulisher
Apr 10, 2026

Verastem (VSTM) Presents Positive Two-Year Data for Ovarian Canc - GuruFocus

Apr 10, 2026
pulisher
Apr 10, 2026

Verastem’s cancer drug combo shows durability in 2-year data By Investing.com - Investing.com India

Apr 10, 2026
pulisher
Apr 10, 2026

Verastem’s cancer drug combo shows durability in 2-year data - Investing.com

Apr 10, 2026
pulisher
Apr 10, 2026

Verastem Oncology announces two-year median follow-up data on Avmapki® Fakzynja® combination therapy - marketscreener.com

Apr 10, 2026

Verastem Inc (VSTM) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$28.32
price down icon 0.14%
$50.44
price up icon 0.48%
$95.50
price down icon 3.88%
$139.44
price down icon 0.41%
$147.21
price down icon 0.47%
ONC ONC
$297.49
price up icon 0.12%
大文字化:     |  ボリューム (24 時間):